Key result
Approximately 40% of patients undergoing PCI have high bleeding risk, facing a ≥4% risk of serious bleeding at 1 year and requiring DAPT for 1 to 6 months.
Discusses the evolving landscape of coronary stents and DAPT duration for patients at high bleeding risk undergoing PCI.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Davide Capodanno (2021) conducted an editorial in High bleeding risk in patients undergoing percutaneous coronary intervention. Dual antiplatelet therapy (DAPT) was evaluated. Approximately 40% of patients undergoing PCI have high bleeding risk, facing a ≥4% risk of serious bleeding at 1 year and requiring DAPT for 1 to 6 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: